Benchmark helps deliver improved healthcare products and welfare services to the global aquaculture and livestock industries. Rising demand from clients for its products and services to manage sustainability practice and performance underlines BMK's opportunity for significant organic and external growth.

26 Aug 2022

Benchmark Holdings - Q3 Results - Investor Presentation video - 25 August 2022

We hosted an investor presentation with Benchmark Holdings plc, the aquaculture biotechnology company, following publication of their Q3 results.

Trond Williksen, CEO, and Septima Maguire, CFO took viewers through the highlights of the period which saw continued business momentum and growth in Adj. EBITDA and progress on the development of a new CleanTreat® configuration and business model. The management team provided a financial review, looking at each key business (Genetics, Advanced Nutrition, Health) and gave an update on the intended Euronext Growth Oslo listing in Q4 2022.

The full video has been divided into chapters.
0:00:03 Introduction and Q3 overview
0:04:22 Business area highlights
0:10:52 New CleanTreat® configuration details
0:13:45 Financial Review
0:20:53 Progress towards listing on Euronext Growth Oslo
0:21:47 Current trading & outlook; Benchmark's unique value proposition
0:26:20 Questions & Answers

Return to Benchmark Holdings

Register to be first

Get research on the companies that interest you straight to your inbox

Equity Development is a partner to successful companies looking to enhance their investor relations. Our top-rated analysts produce best in class investment research. Based in London, UK, we help our clients connect with investors via presentations and interviews.

Equity Development Limited 2nd Floor, Park House, 16-18 Finsbury Circus, London, EC2M 7EB

Website design & development by Breckenridge